Home › Myelodysplastic Syndromes › Georgia › Atlanta
Pag-aaral pangklinika para sa Myelodysplastic Syndromes sa Atlanta, GA
Isang pag-aaral para sa Myelodysplastic Syndromes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Atlanta. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Nagre-recruitPhase 1
- Emory University Hospital/Winship Cancer Institute, Atlanta
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Nagre-recruitPhase 1
- Emory University, Atlanta
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Nagre-recruitPhase 1/2
- Emory Winship Cancer Institute, Atlanta
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Nagre-recruitPhase 3
- Emory University, Atlanta
Collection of Tissue Samples for Cancer Research
Nagre-recruitObservasyonal na pag-aaral
- Emory University, Atlanta
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- Northside Hospital, Atlanta
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Nagre-recruitPhase 2/3
- University of Emory - Winship Cancer Institute, Atlanta
Venetoclax Basket Trial for High Risk Hematologic Malignancies
Nagre-recruitPhase 1
- Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
- Northside Hospital, Atlanta
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Nagre-recruitPhase 1
- Emory University Hospital, Atlanta
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
Nagre-recruitPhase 1
- Emory University, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Atlanta
Pag-aaral para sa Myelodysplastic Syndromes sa ibang lungsod
- Houston, TX43 pag-aaral
- Baldwin Park, CA26 pag-aaral
- New York City, NY21 pag-aaral
- Seattle, WA21 pag-aaral
- Washington, DC20 pag-aaral
- Tampa, FL19 pag-aaral
- Boston, MA19 pag-aaral
- Miami, FL17 pag-aaral
- Durham, NC14 pag-aaral
- Columbus, OH14 pag-aaral
- St. Louis, MO13 pag-aaral
- Chicago, IL13 pag-aaral
Iba pang pag-aaral sa Atlanta
- Kanser (lahat ng uri)49 pag-aaral
- Non-Small Cell Lung Cancer47 pag-aaral
- Multiple Myeloma42 pag-aaral
- Kanser sa Suso41 pag-aaral
- Kanser sa Prostate33 pag-aaral
- Acute Myeloid Leukemia31 pag-aaral
- Kanser sa Ovary29 pag-aaral
- Colorectal Cancer29 pag-aaral
- Kanser sa Baga29 pag-aaral
- Metastatic Cancer28 pag-aaral
- Major Depressive Disorder25 pag-aaral
- Pagkabigo ng Puso25 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.